PART 2: Dr. Richard Urso: Big Pharma Makes Billions by Rebranding Existing Drugs as ‘New’ Products

“We have seen the ultimate demise of our health care system when it’s in the hands of bureaucrats,” says Dr. Richard Urso, a co-founder of the International Alliance of Physicians and Medical Scientists.

Previously, in part one of our interview, we discussed alarming post-booster trends he’s seen and how usual protocols for identifying treatments were thrown out during the COVID-19 pandemic.

Now in part two, we discuss how big pharmaceutical companies can make billions by essentially repackaging existing products.